Clinical Trials
| Cancer Type: Breast | |
| Description: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer | |
| Entity Approving The Trial: Eastern Cooperative Oncology Group (ECOG) |
|
| Phase: III | |
| Site-Wide Accrual Goal: 4,950 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| http://www.cancer.gov/search/viewclinicaltrials.aspx?version=healthprofessional&cdrid=528955 |
 |
 |
|
